Presbyopia awareness: Causes, risk factors, symptoms, correction options and market trends.
The co-chairs of the 2023 Controversies in Modern Eye Care symposium reflect on the day.
How Jimmie Johnson relieves his ocular allergies
Spectacle independence, nighttime glare symptoms often are key factors.
At the Tear Film and Ocular Surface meeting in Venice, Dr. Melissa Toyos shares findings on the mechanism of action of brimonidine tartrate.
Patients with HTG had significantly fewer mtDNA copies per nuclear DNA.
An increase in screen time has led to a rise in binocular vision disorders.
An inside look into a retrospective study conducted from 2019 to 2023 that aimed to assess the effectiveness of treatment and prevention of the progression of uncomplicated acquired myopia through physiotherapeutic methods.
Proper screenings, treatment, management needed for this increasingly prevalent disease.
Refer patients who have reduced vision and functional vision goals
An increase in screen time has led to a rise in binocular vision disorders.
Comanagement optimizes outcomes for patients who wear scleral lenses.
Some markets—including US, Japan, Greece—see opportunities to fit more astigmatic patients
After 10 years, women’s median earnings are 9% less than men’s
Mark E. Wilkinson, OD, FAAO, touches on the importance of understanding the genetics of inherited eye disease, which he presented during the 2022 American Academy of Optometry meeting.
Pamela Theriot OD, FAAO, on highlights from her SECO 2022 presentation "Makeup and the ocular surface: what you need to know"
A few optometrists share which innovations in optometry they were most excited about in 2024.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Treatment requires a systematic, multifaceted approach to improve outcomes.
Three EnVision Summit faculty members weigh in on the importance of comanagement in glaucoma management, where artificial intelligence will lead eye care, and what hopes are on the horizon for corneal ectasia treatments.
Danielle Crull, ABOM, details Truffles' story and new initiatives she has taken on to destigmatize glasses and patching for children.
Davis Corley, CEO of Neurolens, outlines the importance a new study that show statistically significant improvement of headaches with the use of Neurolens.
Optometrists must identify and mitigate complications for this patient base.
Wearable technology options can meet patient’s goals.
On the surface, eyecare providers may not fully appreciate the prevalence and complexity of ocular allergy and its clinical management; we learn that it is a relatively simple disease defined by ocular itch.
How to be optimistic, responsible, and open in the face of new technology.